Baidu
map
IMMUN INFLAMM DIS 润色咨询

Immunity Inflammation and Disease

出版年份：暂无数据 年文章数：471 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2024-07-24 ms7000000628740186 来自山东省

    偏重的研究方向：病毒感染
    经验分享：有让填写arrive guidelines的吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2024-05-31 ms1000001025351229 来自江西省

    编辑一直说ORCID is private是怎么回事

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2023-05-30 147bb595m21暂无昵称g g 来自重庆

    审稿速度:1.0 | 投稿命中率:95.0
    经验分享：333333333333333

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2024-01-14 ms6000001569443492

    under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-04-02 小花🌸

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向：病毒感染
    经验分享：2021-12-28 submitted
    2022-02-15 Major Revison
    2022-03-01 a revision has been submitted
    2022.03.15 accept
    比较容易中，审稿速度也挺快的，就是版面费有点贵。

    15

    展开15条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-12-12 ms3000001223217872

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-09-16 ms3000001223217872

    没送外审给了小修意见，是啥意思啊？

    9

    展开9条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-08-05 ms5000000629917935

    现在还纯生信的吗？

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-09-23 小花🌸

    最近投稿进度怎么样啊？under review 2月了。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2216571, encodeId=e68b22165e18c, content=偏重的研究方向：病毒感染<br>经验分享：有让填写arrive guidelines的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=845a9359849, createdName=ms7000000628740186, createdTime=Wed Jul 24 07:04:17 CST 2024, time=2024-07-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2207626, encodeId=e1b3220e62642, content=编辑一直说ORCID is private是怎么回事, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61599048700, createdName=ms1000001025351229, createdTime=Fri May 31 13:31:33 CST 2024, time=2024-05-31, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139979, encodeId=4fea21399e972, content=审稿速度:1.0 | 投稿命中率:95.0<br>经验分享：333333333333333, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d915239987, createdName=147bb595m21暂无昵称g g, createdTime=Tue May 30 21:56:15 CST 2023, time=2023-05-30, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2181581, encodeId=b2da218158162, content=under review6个月发邮件过去问跟我说with the editors for reviewer assignment，准备改投了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d995446854, createdName=ms6000001569443492, createdTime=Sun Jan 14 18:44:59 CST 2024, time=2024-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208194, encodeId=1ff81208194f5, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向：病毒感染<br>经验分享：2021-12-28 submitted<br>2022-02-15 Major Revison<br>2022-03-01 a revision has been submitted<br>2022.03.15 accept<br>比较容易中，审稿速度也挺快的，就是版面费有点贵。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=194, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Sat Apr 02 17:10:32 CST 2022, time=2022-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105764, encodeId=a6612105e647c, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享：9.8投 9.10小修 9.22返回 大概10月份送审，当时没关注 11.16意见返回，大修 12.3返回去 12.7小修，当天返回 12.12接收 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Mon Dec 12 18:56:16 CST 2022, time=2022-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249403, encodeId=d91612494030f, content=没送外审给了小修意见，是啥意思啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=35b68278514, createdName=ms3000001223217872, createdTime=Fri Sep 16 20:58:04 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236836, encodeId=cab0123683626, content=现在还纯生信的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=daff5480735, createdName=ms5000000629917935, createdTime=Fri Aug 05 21:36:35 CST 2022, time=2022-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090022, encodeId=f33e20900221a, content=最近投稿进度怎么样啊？under review 2月了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=小花🌸, createdTime=Fri Sep 23 20:38:16 CST 2022, time=2022-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202992, encodeId=ce921202992b7, content=有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220223/097b58672a214087b2103b599bd626dc/78cb4a7f57db4cd09709447999f3d717.JPG, createdBy=cfac2332641, createdName=12273049m20(暂无昵称), createdTime=Wed Mar 16 07:11:49 CST 2022, time=2022-03-16, status=1, ipAttribution=)]
    2022-03-16 12273049m20(暂无昵称)

    有没有同道中人投过这个期刊，正规吗？有没有问题，是SCI吧。看medsci里很多数据都缺失了

    2

    展开2条回复
共53条页码: 1/6页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map